2023-10-01 10046614 2024-09-30 10046614 2023-10-01 2024-09-30 10046614 2023-09-30 10046614 2022-10-01 2023-09-30 10046614 uk-core:WithinOneYear 2023-09-30 10046614 uk-core:WithinOneYear 2024-09-30 10046614 uk-core:AfterOneYear 2023-09-30 10046614 uk-core:AfterOneYear 2024-09-30 10046614 uk-core:ShareCapital 2024-09-30 10046614 uk-core:ShareCapital 2023-09-30 10046614 uk-core:RetainedEarningsAccumulatedLosses 2024-09-30 10046614 uk-core:RetainedEarningsAccumulatedLosses 2023-09-30 10046614 uk-bus:Director1 2023-10-01 2024-09-30 10046614 uk-core:CommercialMotorVehicles 2023-09-30 10046614 uk-core:PlantMachinery 2023-09-30 10046614 uk-core:Buildings 2023-09-30 10046614 uk-core:CommercialMotorVehicles 2023-10-01 2024-09-30 10046614 uk-core:PlantMachinery 2023-10-01 2024-09-30 10046614 uk-core:Buildings 2023-10-01 2024-09-30 10046614 uk-core:Buildings 2024-09-30 10046614 uk-core:PlantMachinery 2024-09-30 10046614 uk-core:CommercialMotorVehicles 2024-09-30 10046614 uk-core:WithinOneYear 2024-09-30 10046614 uk-core:WithinOneYear 2023-09-30 iso4217:GBP xbrli:pure 10046614 uk-bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 10046614 uk-bus:FRS102 2023-10-01 2024-09-30 10046614 uk-bus:FilletedAccounts 2023-10-01 2024-09-30 10046614 uk-bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30
Global Pharma Direct Ltd
Registered Number:10046614
For the year ended 30 September 2024
England and Wales
Unaudited Financial Statements
2
For the year ended 30 September 2024
Global Pharma Direct Ltd
Contents Page
1
Statement of Financial Position
2 to 3
Notes to the Financial Statements
3
Registered Number :
10046614
As at 30 September 2024
Global Pharma Direct Ltd
Statement of Financial Position
£
£
2023
2024
Notes
Fixed assets
Property, plant and equipment
196,184
184,847
2
196,184
184,847
Current assets
Inventories
-
23,163
3
Trade and other receivables
74,319
62,299
4
74,617
Cash and cash equivalents
47,742
133,204
148,936
Trade and other payables: amounts falling due within one year
(92,264)
(67,892)
5
56,672
65,312
Net current assets
Total assets less current liabilities
261,496
241,519
Trade and other payables: amounts falling due after more than
one year
(57,021)
(90,463)
6
171,033
Net assets
184,498
Capital and reserves
Called up share capital
1,000
1,000
Retained earnings
170,033
183,498
171,033
184,498
Shareholders' funds
For the year ended 30 September 2024 the company was entitled to exemption from audit under Section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006
The directors acknowledge their responsibilities for:a) ensuring that the company keeps proper accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
b) preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each
financial year and of its profit or loss for each financial year in accordance with the requirements of Section 394 and 395 and
which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as
applicable to the company.
In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Mr Amjid Malik Khan Director
These financial statements were approved and authorised for issue by the Board on 17 February 2025 and were signed by:
The notes form part of these financial statements
1 of 3
4
For the year ended 30 September 2024
Global Pharma Direct Ltd
Notes to the Financial Statements
Statutory Information
Global Pharma Direct Ltd is a private limited company, limited by shares, domiciled in England and Wales, registration number
10046614.
Registered address:
Station Works, Station Road,
Oxenby Drive, Langworth
Lincoln
Linconlshire
LN3 5BB
The presentation currency is £ sterling.
1. Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A of Financial Reporting
Standard 102 ''The Financial Reporting Standard applicable in the UK and Republic of Ireland'' and the Companies Act 2006.
The financial statements have been prepared under the historical costs convention as modified by the revaluation of certain
assets.
2. Property, plant and equipment
Total
Motor Vehicles
Plant and
Machinery
Land and
Buildings
£
£
£
£
Cost or valuation
At 01 October 2023
257,907
104,546
36,727
116,634
28,724
28,724
-
-
Additions
At 30 September 2024
116,634
36,727
133,270
286,631
Provision for depreciation and impairment
At 01 October 2023
73,060
58,853
14,207
-
Charge for year
17,387
14,883
2,504
-
At 30 September 2024
90,447
73,736
16,711
-
At 30 September 2024
Net book value
116,634
20,016
59,534
196,184
At 30 September 2023
116,634
22,520
45,693
184,847
3. Inventories
2023
2024
£
£
Stocks
23,163
-
2 of 3
5
For the year ended 30 September 2024
Global Pharma Direct Ltd
Notes to the Financial Statements Continued
4. Trade and other receivables
2023
2024
£
£
Trade debtors
62,299
74,319
5. Trade and other payables: amounts falling due within one year
2023
2024
£
£
Bank loans and overdraft
29,698
5,768
Trade creditors
9,519
-
Other creditors
28,675
86,496
67,892
92,264
6. Trade and other payables: amounts falling due after more than one year
2023
2024
£
£
Bank loans and overdraft (secured)
7,747
-
Trade creditors
-
21,203
Other creditors
82,716
35,818
90,463
57,021
7. Average number of persons employed
During the year the average number of employees was 0
3 of 3